| 219 Health Network, Inc. | |
|
4320 Fir St Unit 408 East Chicago IN 46312-3078 | |
| (219) 554-4081 | |
| (219) 554-4088 |
| Full Name | 219 Health Network, Inc. |
|---|---|
| Speciality | Clinic/Center |
| Location | 4320 Fir St Unit 408, East Chicago, Indiana |
| Authorized Official Name and Position | Patricia Johnson (CHIEF EXECUTIVE OFFICER) |
| Authorized Official Contact | 2197032585 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| 219 Health Network, Inc. 100 W Chicago Ave Ste F East Chicago IN 46312-3261 Ph: (219) 392-7016 | 219 Health Network, Inc. 4320 Fir St Unit 408 East Chicago IN 46312-3078 Ph: (219) 554-4081 |
| NPI Number | 1811562374 |
|---|---|
| Provider Enumeration Date | 05/26/2021 |
| Last Update Date | 06/01/2021 |
| Medicare PECOS PAC ID | 0547521452 |
|---|---|
| Medicare Enrollment ID | O20210723001938 |
News Archive
A new study suggests that bright light therapy may improve sleep, cognition, emotion and brain function following mild traumatic brain injury (TBI).
Amidst a pitched political debate over the federal deficit, all sides agree that health care spending must be addressed. Still, Medicare continues to cause considerable political differences. At the same time, a new CBS poll finds that Americans have "mixed feelings" about what should happen to the health insurance program for senior citizens.
House Appropriations Committee Chairman David Obey, D-Wis., said Wednesday that groups pressing for $14 billion more in funding for education, health and labor programs will likely be disappointed because the budget proposed by President Barack Obama already faces cuts of about $3.5 billion in those areas.
Bayhill Therapeutics Inc, a clinical-stage biopharmaceutical company leveraging its proprietary BHT-DNA platform to develop targeted autoimmune disease treatments, today announced that it will present at the 26th Congress of the European Committee for the Treatment and Research in Multiple Sclerosis and 15th Annual Conference of Rehabilitation in MS in Gothenburg, Sweden, data from its concluded Phase 2 clinical trial showing that baseline blood plasma anti-MBP (myelin basic protein) profiles identify responders to BHT-3009 treatment.
Two independent teams of researchers have identified a role for enhanced activation of the signaling protein Notch in tumors characterized by inactivation of either the TSC1 or the TSC2 protein. As indicated by Warren Pear, at the University of Pennsylvania, Philadelphia, in an accompanying commentary, these data provide a rationale for testing whether Notch inhibitors are of benefit to those with TSC-associated tumors.
› Verified 9 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1811562374 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | (* (Not Available)) | Secondary |
| 261QF0400X | Clinic/center - Federally Qualified Health Center (fqhc) | (* (Not Available)) | Primary |
News Archive
A new study suggests that bright light therapy may improve sleep, cognition, emotion and brain function following mild traumatic brain injury (TBI).
Amidst a pitched political debate over the federal deficit, all sides agree that health care spending must be addressed. Still, Medicare continues to cause considerable political differences. At the same time, a new CBS poll finds that Americans have "mixed feelings" about what should happen to the health insurance program for senior citizens.
House Appropriations Committee Chairman David Obey, D-Wis., said Wednesday that groups pressing for $14 billion more in funding for education, health and labor programs will likely be disappointed because the budget proposed by President Barack Obama already faces cuts of about $3.5 billion in those areas.
Bayhill Therapeutics Inc, a clinical-stage biopharmaceutical company leveraging its proprietary BHT-DNA platform to develop targeted autoimmune disease treatments, today announced that it will present at the 26th Congress of the European Committee for the Treatment and Research in Multiple Sclerosis and 15th Annual Conference of Rehabilitation in MS in Gothenburg, Sweden, data from its concluded Phase 2 clinical trial showing that baseline blood plasma anti-MBP (myelin basic protein) profiles identify responders to BHT-3009 treatment.
Two independent teams of researchers have identified a role for enhanced activation of the signaling protein Notch in tumors characterized by inactivation of either the TSC1 or the TSC2 protein. As indicated by Warren Pear, at the University of Pennsylvania, Philadelphia, in an accompanying commentary, these data provide a rationale for testing whether Notch inhibitors are of benefit to those with TSC-associated tumors.
› Verified 9 days ago
219 Health Network, Inc. Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 4320 Fir St Unit 216, East Chicago, IN 46312 Phone: 219-392-7025 | |
Immanuel Family Health Center Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 915 W Chicago Ave, East Chicago, IN 46312 Phone: 219-397-6000 Fax: 219-397-6358 | |
219 Health Network Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1802 E Columbus Dr, East Chicago, IN 46312 Phone: 219-397-6916 Fax: 219-397-9313 | |
Nwi Home Doctor Llc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 3847 Euclid Ave, East Chicago, IN 46312 Phone: 219-949-7540 | |
219 Health Network Inc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 100 W Chicago Ave Ste F, East Chicago, IN 46312 Phone: 219-392-7016 | |
St Catherine Care Network Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 100 West Chicago Avenue, Suite F, East Chicago, IN 46312 Phone: 219-397-0193 Fax: 219-397-0657 | |
Elgin Surgicare Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 521 W Chicago Ave, East Chicago, IN 46312 Phone: 630-345-0834 |